Cargando…
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia
Hepatocellular Carcinoma (HCC) is a leading cause of cancer-related death worldwide. Globally, the most important HCC risk factors are Hepatitis B Virus (HBV) and/or Hepatitis C Virus (HCV), chronic alcoholism, and dietary exposure to aflatoxins. We have described the epidemiological pattern of 202...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207138/ https://www.ncbi.nlm.nih.gov/pubmed/22114738 http://dx.doi.org/10.1155/2011/582945 |
_version_ | 1782215524052107264 |
---|---|
author | Navas, Maria-Cristina Suarez, Iris Carreño, Andrea Uribe, Diego Rios, Wilson Alfredo Cortes-Mancera, Fabian Martel, Ghyslaine Vieco, Beatriz Lozano, Diana Jimenez, Carlos Gouas, Doriane Osorio, German Hoyos, Sergio Restrepo, Juan Carlos Correa, Gonzalo Jaramillo, Sergio Lopez, Rocio Bravo, Luis Eduardo Arbelaez, Maria Patricia Scoazec, Jean-Yves Abedi-Ardekani, Behnoush Santella, Regina M. Chemin, Isabelle Hainaut, Pierre |
author_facet | Navas, Maria-Cristina Suarez, Iris Carreño, Andrea Uribe, Diego Rios, Wilson Alfredo Cortes-Mancera, Fabian Martel, Ghyslaine Vieco, Beatriz Lozano, Diana Jimenez, Carlos Gouas, Doriane Osorio, German Hoyos, Sergio Restrepo, Juan Carlos Correa, Gonzalo Jaramillo, Sergio Lopez, Rocio Bravo, Luis Eduardo Arbelaez, Maria Patricia Scoazec, Jean-Yves Abedi-Ardekani, Behnoush Santella, Regina M. Chemin, Isabelle Hainaut, Pierre |
author_sort | Navas, Maria-Cristina |
collection | PubMed |
description | Hepatocellular Carcinoma (HCC) is a leading cause of cancer-related death worldwide. Globally, the most important HCC risk factors are Hepatitis B Virus (HBV) and/or Hepatitis C Virus (HCV), chronic alcoholism, and dietary exposure to aflatoxins. We have described the epidemiological pattern of 202 HCC samples obtained from Colombian patients. Additionally we investigated HBV/HCV infections and TP53 mutations in 49 of these HCC cases. HBV biomarkers were detected in 58.1% of the cases; HBV genotypes F and D were characterized in three of the samples. The HCV biomarker was detected in 37% of the samples while HBV/HCV coinfection was found in 19.2%. Among TP53 mutations, 10.5% occur at the common aflatoxin mutation hotspot, codon 249. No data regarding chronic alcoholism was available from the cases. In conclusion, in this first study of HCC and biomarkers in a Colombian population, the main HCC risk factor was HBV infection. |
format | Online Article Text |
id | pubmed-3207138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32071382011-11-23 Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia Navas, Maria-Cristina Suarez, Iris Carreño, Andrea Uribe, Diego Rios, Wilson Alfredo Cortes-Mancera, Fabian Martel, Ghyslaine Vieco, Beatriz Lozano, Diana Jimenez, Carlos Gouas, Doriane Osorio, German Hoyos, Sergio Restrepo, Juan Carlos Correa, Gonzalo Jaramillo, Sergio Lopez, Rocio Bravo, Luis Eduardo Arbelaez, Maria Patricia Scoazec, Jean-Yves Abedi-Ardekani, Behnoush Santella, Regina M. Chemin, Isabelle Hainaut, Pierre Hepat Res Treat Research Article Hepatocellular Carcinoma (HCC) is a leading cause of cancer-related death worldwide. Globally, the most important HCC risk factors are Hepatitis B Virus (HBV) and/or Hepatitis C Virus (HCV), chronic alcoholism, and dietary exposure to aflatoxins. We have described the epidemiological pattern of 202 HCC samples obtained from Colombian patients. Additionally we investigated HBV/HCV infections and TP53 mutations in 49 of these HCC cases. HBV biomarkers were detected in 58.1% of the cases; HBV genotypes F and D were characterized in three of the samples. The HCV biomarker was detected in 37% of the samples while HBV/HCV coinfection was found in 19.2%. Among TP53 mutations, 10.5% occur at the common aflatoxin mutation hotspot, codon 249. No data regarding chronic alcoholism was available from the cases. In conclusion, in this first study of HCC and biomarkers in a Colombian population, the main HCC risk factor was HBV infection. Hindawi Publishing Corporation 2011 2011-10-31 /pmc/articles/PMC3207138/ /pubmed/22114738 http://dx.doi.org/10.1155/2011/582945 Text en Copyright © 2011 Maria-Cristina Navas et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Navas, Maria-Cristina Suarez, Iris Carreño, Andrea Uribe, Diego Rios, Wilson Alfredo Cortes-Mancera, Fabian Martel, Ghyslaine Vieco, Beatriz Lozano, Diana Jimenez, Carlos Gouas, Doriane Osorio, German Hoyos, Sergio Restrepo, Juan Carlos Correa, Gonzalo Jaramillo, Sergio Lopez, Rocio Bravo, Luis Eduardo Arbelaez, Maria Patricia Scoazec, Jean-Yves Abedi-Ardekani, Behnoush Santella, Regina M. Chemin, Isabelle Hainaut, Pierre Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia |
title | Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia |
title_full | Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia |
title_fullStr | Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia |
title_full_unstemmed | Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia |
title_short | Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia |
title_sort | hepatitis b and hepatitis c infection biomarkers and tp53 mutations in hepatocellular carcinomas from colombia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207138/ https://www.ncbi.nlm.nih.gov/pubmed/22114738 http://dx.doi.org/10.1155/2011/582945 |
work_keys_str_mv | AT navasmariacristina hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT suareziris hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT carrenoandrea hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT uribediego hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT rioswilsonalfredo hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT cortesmancerafabian hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT martelghyslaine hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT viecobeatriz hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT lozanodiana hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT jimenezcarlos hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT gouasdoriane hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT osoriogerman hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT hoyossergio hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT restrepojuancarlos hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT correagonzalo hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT jaramillosergio hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT lopezrocio hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT bravoluiseduardo hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT arbelaezmariapatricia hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT scoazecjeanyves hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT abediardekanibehnoush hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT santellareginam hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT cheminisabelle hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia AT hainautpierre hepatitisbandhepatitiscinfectionbiomarkersandtp53mutationsinhepatocellularcarcinomasfromcolombia |